Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday tips round-up: Tate&Lyle, BTG

Thu, 02nd Apr 2015 23:49

Tate&Lyle surprised investors with its full-year pre-tax profit guidance. However, while management has drawn a line under a horrendous 2014 it has a lot of hard work ahead to shore-up investor confidence. The outfit now expects profits of between £230 to £245m, which is "modestly" lower than previous guidance. Significantly, managament hinted that a decision on its troubled Sucralose unit - which has been dogged by Chinese competition - is now imminent.This year the strengthening US dollar will contribute to net debt above the £466m which it was carrying at the end of 2014. Nonetheless, the new low-calorie sugar , Allulose, which it is adding to its product portfolio, has long-term potential. The final fate of Sucralose will be key for sentiment but hold onto the shares for the income they provide, writes The Times's Tempus.Healthcare outfit BTG is seeing better than expected progress at recently acquired PneumRx and its new foam to treat variose veins could double the company's entire annual revenue. The purchase of PneumRx was closed at the end of the year. While the purchase price $475m raised some eyebrows the firm's treatment for patients with serious lung sickness seems to be doing well. After 18 years of development, it remains to be seen whether doctors will endorse its new foam treatment, but according to some analysts annual sales could eventually reach $650m. Hence, recent softness in the shares represents an opportunity to buy them for the long-term, Tempus says.
More News
18 May 2018 10:32

WINNERS & LOSERS SUMMARY: Retailer Carpetright Rises On Fundraising

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------DS up 2.1%. to

Read more
15 May 2018 12:07

LONDON MARKET MIDDAY: UK Wages In Line But Fail To Inspire Pound

LONDON (Alliance News) - Despite a lower open, the FTSE 100 was trading around its best levels since late January by midday on Tuesday as the latest UK wage data failed to inspire the pound.Rising in

Read more
15 May 2018 11:07

BTG Swings To Annual Loss On PneumRx Coils Impairment Charges

LONDON (Alliance News) - BTG PLC on Tuesday swung to a pretax loss for the recently ended financial year due to a large impairment charge relating to PneumRx Coils, used to treat lung disease the

Read more
15 May 2018 10:37

WINNERS & LOSERS SUMMARY: Vodafone Stumbles As CEO Stands Down

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 3.3%. The budget airline said it saw a first

Read more
15 May 2018 08:32

LONDON MARKET OPEN: easyJet Rises While Vodafone Falls; UK Wages Due

LONDON (Alliance News) - The FTSE 100 was largely unchanged early Tuesday, with easyJet and Vodafone respectively topping and tailing the blue-chip index."In be

Read more
8 May 2018 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 9 May Coca-Cola HBCQ1 ResultsIAGMay Traffic Statistics (at 1500 Year Year 10 11

Read more
5 Dec 2016 07:08

BTG product gets two ticks of approval

(ShareCast News) - Global specialist healthcare company BTG announced the inclusion of treatment with its PneumRx Coils product in guidelines for the management of chronic obstructive pulmonary disease on Monday, as published by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The

Read more
16 Nov 2016 09:55

BROKER RATINGS SUMMARY: Goldman And Deutsche Raise Miner Price Targets

Read more
15 Nov 2016 10:41

WINNERS & LOSERS SUMMARY: Intermediate Capital And Polypipe Surge

Read more
15 Nov 2016 08:13

BTG First Half Profit Slumps Due To Settlement And Currency Impact

Read more
15 Nov 2016 07:41

Interventional medicine revenue surges at BTG

(ShareCast News) - Specialist healthcare company BTG posted its interim results for the six months to 30 September on Tuesday, with double-digit revenue growth underpinned by 24% constant exchange rate growth in interventional medicine revenues. The FTSE 250 firm said its operating profit for the pe

Read more
1 Nov 2016 10:29

WINNERS & LOSERS SUMMARY: Standard Chartered Sold As Profit Misses

Read more
26 Oct 2016 17:40

Wednesday broker round-up

(ShareCast News) - FirstGroup: Goldman Sachs keeps at buy with a target price of 168p. Esure: Berenberg stays at sell, 238p target. Anglo American: Deutsche Bank reiterates hold with a 965p target. Intertek: UBS reiterates buy with a 4100p target. Sainsbury: Goldman Sachs reiterates sell with a 1

Read more
26 Oct 2016 08:29

BROKER RATINGS SUMMARY: Goldman Slightly Less Negative On UK Grocers

Read more
25 Oct 2016 06:37

Clinigen Group Extends Exclusive Supply Agreement With BTG

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.